Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Central glucocorticoid administration promotes weight gain and increased 11β-hydroxysteroid dehydrogenase type 1 expression in white adipose tissue.

Veyrat-Durebex C, Deblon N, Caillon A, Andrew R, Altirriba J, Odermatt A, Rohner-Jeanrenaud F.

PLoS One. 2012;7(3):e34002. doi: 10.1371/journal.pone.0034002.

2.

Neonatal overfeeding induced by small litter rearing causes altered glucocorticoid metabolism in rats.

Hou M, Liu Y, Zhu L, Sun B, Guo M, Burén J, Li X.

PLoS One. 2011;6(11):e25726. doi: 10.1371/journal.pone.0025726.

3.

Role of glucocorticoids in the physiopathology of excessive fat deposition and insulin resistance.

Asensio C, Muzzin P, Rohner-Jeanrenaud F.

Int J Obes Relat Metab Disord. 2004 Dec;28 Suppl 4:S45-52. Review.

PMID:
15592486
4.

Dietary fatty acid composition alters 11β-hydroxysteroid dehydrogenase type 1 gene expression in rat retroperitoneal white adipose tissue.

Vara Prasad SS, Jeya Kumar SS, Kumar PU, Qadri SS, Vajreswari A.

Lipids Health Dis. 2010 Oct 8;9:111. doi: 10.1186/1476-511X-9-111.

5.

Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.

Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC, Staels B, Seckl JR, Mullins JJ.

Proc Natl Acad Sci U S A. 2004 May 4;101(18):7088-93.

6.

Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta.

Sai S, Esteves CL, Kelly V, Michailidou Z, Anderson K, Coll AP, Nakagawa Y, Ohzeki T, Seckl JR, Chapman KE.

Mol Endocrinol. 2008 Sep;22(9):2049-60. doi: 10.1210/me.2007-0489.

PMID:
18617597
7.
8.

Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.

Paulsen SK, Nielsen MP, Richelsen B, Bruun JM, Flyvbjerg A, Pedersen SB.

Obesity (Silver Spring). 2008 Apr;16(4):731-5. doi: 10.1038/oby.2008.2.

9.

Insulin and dexamethasone dynamically regulate adipocyte 11beta-hydroxysteroid dehydrogenase type 1.

Balachandran A, Guan H, Sellan M, van Uum S, Yang K.

Endocrinology. 2008 Aug;149(8):4069-79. doi: 10.1210/en.2008-0088.

10.

11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.

Harno E, Cottrell EC, Keevil BG, DeSchoolmeester J, Bohlooly-Y M, Andersén H, Turnbull AV, Leighton B, White A.

Endocrinology. 2013 Oct;154(10):3599-609. doi: 10.1210/en.2013-1362.

PMID:
23832962
12.

Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.

Ignatova ID, Kostadinova RM, Goldring CE, Nawrocki AR, Frey FJ, Frey BM.

Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E367-77. doi: 10.1152/ajpendo.90531.2008.

13.

Regulation of adipocyte 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) by CCAAT/enhancer-binding protein (C/EBP) β isoforms, LIP and LAP.

Esteves CL, Kelly V, Bégay V, Man TY, Morton NM, Leutz A, Seckl JR, Chapman KE.

PLoS One. 2012;7(5):e37953. doi: 10.1371/journal.pone.0037953.

14.

Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue.

Apostolova G, Schweizer RA, Balazs Z, Kostadinova RM, Odermatt A.

Am J Physiol Endocrinol Metab. 2005 May;288(5):E957-64.

15.
16.

In vivo activity of 11β-hydroxysteroid dehydrogenase type 1 in man: effects of prednisolone and chenodesoxycholic acid.

Diederich S, Quinkler M, Mai K, Schöneshöfer M, Baehr V, Pfeiffer A, Oelkers W, Eigendorff E.

Horm Metab Res. 2011 Jan;43(1):66-71. doi: 10.1055/s-0030-1267170.

PMID:
20925019
17.

Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.

Stimson RH, Walker BR.

Minerva Endocrinol. 2007 Sep;32(3):141-59. Review.

PMID:
17912154
18.

Effect of hyperlipidemia on 11β-hydroxysteroid-dehydrogenase, glucocorticoid receptor, and leptin expression in insulin-sensitive tissues of cats.

Sieber-Ruckstuhl NS, Zini E, Osto M, Franchini M, Boretti FS, Meli ML, Sigrist B, Lutz TA, Reusch CE.

Domest Anim Endocrinol. 2010 Nov;39(4):222-30. doi: 10.1016/j.domaniend.2010.06.003.

PMID:
20688460
19.

Dietary manipulation reveals an unexpected inverse relationship between fat mass and adipose 11β-hydroxysteroid dehydrogenase type 1.

Man TY, Michailidou Z, Gokcel A, Ramage L, Chapman KE, Kenyon CJ, Seckl JR, Morton NM.

Am J Physiol Endocrinol Metab. 2011 Jun;300(6):E1076-84. doi: 10.1152/ajpendo.00531.2010.

20.

Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.

Baudrand R, Domínguez JM, Carvajal CA, Riquelme A, Campino C, Macchiavello S, Bozinovic M, Morales M, Pizarro M, Solis N, Escalona A, Boza C, Arrese M, Fardella CE.

Metabolism. 2011 Dec;60(12):1775-80. doi: 10.1016/j.metabol.2011.05.001.

PMID:
21704348
Items per page

Supplemental Content

Support Center